Research On Marketing Strategy Of M Pharmaceutical Trading Company In India Market

The pharmaceutical industry is a sunrise industry.With the rapid development of social economy and the continuous improvement of people's living standards,the health awareness of the whole people has been raised,and the medical policies and welfare treatment of various countries in the world have also been improved.This is bound to bring opportunities for the sustainable development of the pharmaceutical industry.In the early days of the founding of the people's Republic of China,the foundation of the pharmaceutical industry,especially the raw material medicine industry,was rather weak.With the spring of reform and opening up,the state has implemented a series of measures to rectify the pharmaceutical industry,helping the pharmaceutical industry to embark on a standardized reform path.Since the early 1990 s,China's pharmaceutical industry has made great development and progress,among which raw material drug production The strength of manufacturing enterprises has been greatly enhanced,and the global production center of gravity has gradually shifted to the developing countries represented by China and India.Since then,our country's API industry has been on a steady track of development.After 2011,China has become the largest country in the world in the production and export of APIs,and at the same time,pharmaceutical and foreign trade companies have sprung up one after another.Contributing to the development of our country's API market.M Company is a foreign trade company engaged in pharmaceutical import and export trade.Its main export target is the Indian market.India,like our own,is also a major producer and exporter of APIs in the world,but as a result of the Restricted by geography,climate and other factors,India cannot produce raw materials in its own country,so it needs to be imported from China.In addition,because of its very strict environmental laws,The production of intermediates requires a large amount of chemical activity,which leads to the need for India to import corresponding intermediates from China.According to relevant data,at present,60% to 70% of the intermediates in India need to be imported from China,but India itself will also produce some of the raw materials needed.It can be said that there is a subtle competition between China and India in the API industry,as well as the relationship between supply and demand.Therefore,M foreign trade company wants to further develop the Indian market.We should make a corresponding analysis of the current marketing environment and the enterprise's own environment so as to formulate appropriate marketing strategies.Based on the above research background,the article has carried on the following related research: the first step,the article elaborated the research background and the significance,and has carried on the comb to the foreign trade enterprise international marketing present situation and the medicine enterprise product marketing present situation;The second step is the theoretical part of the article,which discusses 4P theory,SWOT analysis,PEST analysis and five-force model theory.The third step,combined with the PEST analysis theory,focuses on the analysis of M pharmaceutical foreign trade company external marketing in India,the political,economic,social,technological environment factors,but also combined with the five-force model to analyze the current marketing environment of M pharmaceutical enterprises;Step four,knot According to the SWOT analysis method,this paper analyzes the advantages,disadvantages,opportunities and threats of the internal marketing environment of M Pharmaceutical Foreign Trade Company,and puts forward the Indian marketing strategy of M Pharmaceutical Foreign Trade Company by using the 4p theory,and analyzes the advantages,disadvantages,opportunities and threats of the internal marketing environment of M Pharmaceutical Foreign Trade Co.,Ltd.The sixth step is to summarize and summarize the research and analysis of the full text.